Ustekinumab for psoriatic arthritis

Lancet. 2009 Feb 21;373(9664):605-6. doi: 10.1016/S0140-6736(09)60141-0. Epub 2009 Feb 11.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Psoriatic / complications
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Psoriatic / metabolism
  • Cross-Over Studies
  • Double-Blind Method
  • Humans
  • Psoriasis / classification
  • Psoriasis / complications
  • Psoriasis / drug therapy
  • Randomized Controlled Trials as Topic
  • Severity of Illness Index
  • Treatment Outcome
  • Ustekinumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Ustekinumab